Latest News and Press Releases
Want to stay updated on the latest news?
-
Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy Data support...
-
LONDON, Ontario, June 21, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen im Bereich sauberer...
-
LONDON, Ontario, 21 juin 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ci-après « Aduro » ou la « Société » (Nasdaq : ADUR, CSE :ACT (FSE : 9D5), une entreprise de technologie propre qui...
-
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
-
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Logan Ridge Finance Corporation (NASDAQ: LRFC) (“Logan Ridge” or “LRFC”) announced today that it obtained shareholder approval for the merger of LRFC with...
-
Stockholders of PTMN Who Have Voted Thus Far Have Expressed Strong Support for the Proposed Merger, with Favorability in Excess of 85% Logan Ridge Stockholders Approved Merger at its Special...
-
New York, New York, June 20, 2025 (GLOBE NEWSWIRE) -- Axiom Intelligence Acquisition Corp 1 (NASDAQ:AXINU) (the “Company”) today announced the closing of its initial public offering of 20,000,000...
-
BROOKLYN, N.Y., June 20, 2025 (GLOBE NEWSWIRE) -- Pioneer Acquisition I Corp (Nasdaq: PACHU) (the “Company”) today announced that it closed its initial public offering of 25,300,000 units at $10.00...
-
BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) today announced that it has postponed its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which was...
-
Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering
Aduro closed its over-allotment option, raising US$1.2M through additional shares and warrants to support R&D, demo plant build, and operations.